SINGAPORE, Oct. 21, 2024 /PRNewswire/ -- Moleac is excited to announce a significant milestone in t...
* SATURN study aimed at assessing the safety and effects of a 6-month course of NeuroAiD (MLC601/...
SINGAPORE, Jan. 13, 2022 /PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE st...
SINGAPORE, May 31, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, anno...
SINGAPORE, May 6, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, wins ...
SINGAPORE, April 14, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, an...